Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Phosphonic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7932016 | 0.88 | — | — | |
| SCHEMBL6686090 | 0.82 | SLC34A1 (0.35) | LMNA | |
| Potassium Ion SCHEMBL3983738 | 0.82 | — | — | |
| Phosphoric Acid SCHEMBL28353739 | 0.72 | LMNA (0.46) | LMNA | |
| Phosphonic Acid SCHEMBL11781168 | 0.70 | GABRR1 (0.31) | — | |
| SCHEMBL11022013 | 0.69 | — | — | |
| Phosphoric Acid SCHEMBL27767980 | 0.69 | SLC34A1 (0.53) | LMNA | |
| SCHEMBL28476793 | 0.69 | LMNA (0.32) | LMNA | |
| Propylene Glycol SCHEMBL29008138 | 0.69 | TDP1 (0.59) | LMNA | |
| Phosphonic Acid SCHEMBL7193169 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7534272-B2 | Agent for oxidative treatment, particularly in transparent gel form | WELLA AG (DE) | 2009-05-19 | — | — | US | claimed |
| EP-1732505-B1 | OXIDATIVE TREATMENT AGENT, PARTICULARLY IN THE FORM OF A TRANSPARENT GEL | WELLA AG (DE) | 2008-12-24 | — | — | EP | claimed |
| EP-1893296-A1 | PRODUCT RELEASE SYSTEM FOR ATOMIZING COMPOSITIONS CONTAINING HAIR-KERATIN-REDUCING OR OXIDATIVE ACTIVE INGREDIENTS | Wella Aktiengesellschaft (DE) | 2008-03-05 | — | — | EP | claimed |
| US-20080038206-A1 | Product release system for atomizing compositions containing hair-keratin-reducing or oxidative active ingredients | PROCTER & GAMBLE COMPANY, THE | 2008-02-14 | — | — | US | claimed |
| US-20070151044-A1 | Agent for oxidative treatment, particularly in transparent gel form | Wella GmbH (DE) | 2007-07-05 | — | — | US | claimed |
| WO-2007002044-A1 | PRODUCT RELEASE SYSTEM FOR ATOMIZING COMPOSITIONS CONTAINING HAIR-KERATIN-REDUCING OR OXIDATIVE ACTIVE INGREDIENTS | THE PROCTER & GAMBLE COMPANY (US) | 2007-01-04 | — | — | WO | claimed |
| US-20260021459-A1 | SUBSTRATE PROCESSING DEVICE, LIQUID SUPPLY DEVICE, AND SUBSTRATE PROCESSING METHOD | TOKYO OHKA KOGYO CO LTD (JP) | 2026-01-22 | — | — | US | disclosed |
| EP-3578161-B1 | METHOD FOR IMPROVING STORAGE STABILITY OF COSMETIC | ADEKA CORP (JP) | 2025-11-12 | — | — | EP | disclosed |
| EP-4620453-A1 | AQUEOUS DISPERSION OF SURFACE-HYDROPHOBIZED INORGANIC POWDER AND COSMETIC PREPARATION CONTAINING SAME | Nikko Chemicals Co., Ltd. (JP) | 2025-09-24 | — | — | EP | disclosed |
| EP-4516317-A1 | DERMATOLOGICAL TOPICAL AGENT COMPOSITION CONTAINING USEFUL COMPONENT-INCLUDING TAURINE CRYSTALS | Cosmed Pharmaceutical Co., Ltd. (JP) | 2025-03-05 | — | — | EP | disclosed |
| EP-3107987-B2 | MACHINE DISHWASH COMPOSITION | UNILEVER GLOBAL IP LTD (GB) | 2024-11-06 | — | — | EP | disclosed |
| EP-4458422-A1 | SKIN CARE COMPOSITION FOR APPLICATION TO SKIN | Cosmed Pharmaceutical Co., Ltd. (JP) | 2024-11-06 | — | — | EP | disclosed |
| US-20240252403-A1 | SKIN CARE COMPOSITION FOR APPLICATION TO SKIN | COSMED PHARMACEUTICAL CO., LTD. (JP) | 2024-08-01 | — | — | US | disclosed |
| EP-0728469-A2 | An endermic liniment | SHISEIDO COMPANY LIMITED (JP) | 1996-08-28 | — | — | EP | disclosed |
| EP-0487404-B1 | External dermatological composition | HAYASHIBARA BIOCHEM LAB (JP) | 1995-10-11 | — | — | EP | disclosed |
| EP-0487404-A1 | External dermatological composition | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 1992-05-27 | — | — | EP | disclosed |
| US-4828766-A | FROM 1-/ACYL/-ETHANE-1,1-DIPHOSPHONIC ACID | BENCKISER-KNAPSACK GMBH (DE) | 1989-05-09 | — | — | US | disclosed |
| EP-0068584-B1 | BORON CONTAINING POLYPHOSPHONATES FOR THE TREATMENT OF CALCIFIC TUMORS | THE PROCTER & GAMBLE COMPANY (US) | 1985-09-25 | — | — | EP | disclosed |
| US-4399817-A | Boron containing polyphosphonates for the treatment of calcific tumors | THE PROCTER & GAMBLE COMPANY (US) | 1983-08-23 | — | — | US | disclosed |
| EP-0068584-A1 | Boron containing polyphosphonates for the treatment of calcific tumors | THE PROCTER & GAMBLE COMPANY (US) | 1983-01-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260021459-A1 | SUBSTRATE PROCESSING DEVICE, LIQUID SUPPLY DEVICE, AND SUBSTRATE PROCESSING METHOD | HAO2, GFER, LPO | LMNA 3012/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.